Riskpilot← Back to searchSign inGet full accessPRP Kliniken Sverige AB
ABActiveOrg 5569906554Kungsholmsgatan 10 1 TrMedical specialists activities · NACE 8622Est. 201433 employees
Revenue 2024
SEK 50,4M
+7% vs 2023
EBITDA margin
9.5%
-26% vs 2023
Equity ratio
37.7%
Financial strength
Net profit 2024
SEK 3,7M
-60% vs 2023
| Revenue | SEK 50,4M | +7% |
| EBITDA | SEK 4,8M | -26% |
| Net profit | SEK 3,7M | -60% |
| Total assets | SEK 17,2M | -23% |
| Equity | SEK 6,5M | -38% |
| Employees | 33 | — |
Legal name
PRP Kliniken Sverige AB
Org number
5569906554
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
17 november 2014
Share capital
SEK 50 000
Employees
33 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna suppleanten
Company purpose
Bolaget ska bedriva medicinsk vård, utveckla medicintekniska produkter och genomföra kliniska studier kring biomedicinska produkter samt därmed förenlig verksamhet.
Address
Kungsholmsgatan 10 1 Tr
Phone
+468200018
Email
info@nordichair.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 18 184 | 45 479 | 45 953 | 47 072 | 50 441 |
| Staff expenses | — | — | −15 754 | −18 851 | — |
| EBITDA | 3 354 | 10 148 | 7 662 | 6 498 | 4 813 |
| Depreciation & amort. | −78 | −166 | −238 | −255 | −238 |
| EBIT | 3 276 | 9 982 | 7 424 | 6 243 | 4 575 |
| Net financials | −7 | −190 | −30 | 164 | 175 |
| Profit before tax | 2 431 | 7 292 | 5 594 | 11 835 | 4 751 |
| Tax | −539 | −1 596 | −1 187 | −2 495 | −1 030 |
| Net profit | 1 892 | 5 696 | 4 407 | 9 340 | 3 721 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 10 301 | 18 988 | 21 546 | 22 261 | 17 170 |
| Equity | 1 943 | 5 839 | 5 245 | 10 386 | 6 465 |
| Long-term debt | 0 | 0 | — | — | 0 |
| Short-term debt | 7 230 | 9 521 | 10 873 | 11 875 | 10 705 |
| Total debt | 7 230 | 9 521 | 10 873 | 11 875 | 10 705 |
EBITDA margin
9.5%
This company
15.8%
Market median
-40% vs market
20202024
Equity ratio
37.7%
This company
38.2%
Market median
+1% vs market
20202024
Return on equity
57.6%
This company
18.4%
Market median
+213% vs market
20202024
Net profit margin
7.4%
This company
8.1%
Market median
-9% vs market
20202024
Asset turnover
2.94×
This company
1.12×
Market median
+162% vs market
20202024
Debt / equity
1.66×
This company
0.62×
Market median
-168% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
KR Audit | Audit | 2024 |
BM Chief Executive Officer | Chief Executive Officer | 2020 |
MH Auditor Substitute | Auditor Substitute | 2024 |
| Former (2) | ||
JL Auditor Substitute | Auditor Substitute | 2020 – 2024 |
AT Audit | Audit | 2020 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of PRP Kliniken Sverige AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl Rasmus Mandel | Audit | 0 companies |
| Bo Mats Henry Stolt | Chief Executive Officer | 0 companies |
| Marcus Hans Eric Jönsson Vallas | Auditor Substitute | 0 companies |
| Jenny Louise Gentele | Auditor Substitute | 0 companies |
| Angelika Thor | Audit | 0 companies |
| Mina Margaretha Olivia Stolt | Deputy Board Member | 0 companies |
| Anna Maria Margaretha Stolt | Chairman | 0 companies |